112 related articles for article (PubMed ID: 28904727)
1. Post-ivermectin encephalopathy in Senegal: a case report.
Massi DG; Mansare ML; Traoré M; Ndiaye M; Diop AG; Ndiaye MM
Pan Afr Med J; 2017; 27():202. PubMed ID: 28904727
[TBL] [Abstract][Full Text] [Related]
2. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of
Arrey-Agbor DB; Nana-Djeunga HC; Mogoung-Wafo AE; Mafo M; Danwe C; Kamgno J
Am J Trop Med Hyg; 2018 Jul; 99(1):112-115. PubMed ID: 29741149
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of the prevention of post-ivermectin Loa loa encephalopathy by administration of initial low dose].
Kamgno J; Gardon J; Boussinesq M
Med Trop (Mars); 2000; 60(3):275-7. PubMed ID: 11258063
[TBL] [Abstract][Full Text] [Related]
5. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
[TBL] [Abstract][Full Text] [Related]
6. Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp.
Kamgno J; Boussinesq M; Labrousse F; Nkegoum B; Thylefors BI; Mackenzie CD
Am J Trop Med Hyg; 2008 Apr; 78(4):546-51. PubMed ID: 18385346
[TBL] [Abstract][Full Text] [Related]
7. First case of ivermectin-induced severe hepatitis.
Veit O; Beck B; Steuerwald M; Hatz C
Trans R Soc Trop Med Hyg; 2006 Aug; 100(8):795-7. PubMed ID: 16682062
[TBL] [Abstract][Full Text] [Related]
8. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M
Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279
[TBL] [Abstract][Full Text] [Related]
9. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis.
Boussinesq M; Gardon J; Gardon-Wendel N; Kamgno J; Ngoumou P; Chippaux JP
Am J Trop Med Hyg; 1998 Apr; 58(4):461-9. PubMed ID: 9574793
[TBL] [Abstract][Full Text] [Related]
10. Loiasis: African eye worm.
Padgett JJ; Jacobsen KH
Trans R Soc Trop Med Hyg; 2008 Oct; 102(10):983-9. PubMed ID: 18466939
[TBL] [Abstract][Full Text] [Related]
11. Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
Bennuru S; Pion SD; Kamgno J; Wanji S; Nutman TB
PLoS Negl Trop Dis; 2014 Sep; 8(9):e3180. PubMed ID: 25232954
[TBL] [Abstract][Full Text] [Related]
12. Where next with Loa loa encephalopathy? Data are badly needed.
Mackenzie C; Geary T; Prichard R; Boussinesq M
Trends Parasitol; 2007 Jun; 23(6):237-8. PubMed ID: 17459773
[No Abstract] [Full Text] [Related]
13. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
[TBL] [Abstract][Full Text] [Related]
14. [Safety of oral ivermectin in children].
Chosidow A; Gendrel D
Arch Pediatr; 2016 Feb; 23(2):204-9. PubMed ID: 26697814
[TBL] [Abstract][Full Text] [Related]
15. Ivermectin-induced fixed drug eruption in an elderly Cameroonian: a case report.
Ngwasiri CA; Abanda MH; Aminde LN
J Med Case Rep; 2018 Sep; 12(1):254. PubMed ID: 30201032
[TBL] [Abstract][Full Text] [Related]
16. What are the mechanisms associated with post-ivermectin serious adverse events?
Boussinesq M; Kamgno J; Pion SD; Gardon J
Trends Parasitol; 2006 Jun; 22(6):244-6. PubMed ID: 16632406
[No Abstract] [Full Text] [Related]
17. Lymphatic filariasis.
Prescrire Int; 2008 Feb; 17(93):36. PubMed ID: 18383658
[TBL] [Abstract][Full Text] [Related]
18. Successful management of ivermectin-induced blindness in an African lion (Panthera leo) by intravenous administration of a lipid emulsion.
Saqib M; Abbas G; Mughal MN
BMC Vet Res; 2015 Nov; 11():287. PubMed ID: 26612612
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic problems in a patient with amicrofilaremic Loa loa.
Yoshikawa M; Ouji Y; Hayashi N; Moriya K; Nishiofuku M; Ishizaka S; Itoh M; Kimura E; Nakamura F; Nawa Y
J Travel Med; 2008; 15(1):53-7. PubMed ID: 18217871
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy and tolerance of ivermectin (Mectizan) prescribed for the patient with multiple filarial infections (Loa loa/Onchocerca and/or M. perstans)].
Richard-Lenoble D; Kombila M; Chandenier J; Gaxotte P
Bull Soc Pathol Exot Filiales; 1989 Jan; 82(1):65-71. PubMed ID: 2743519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
